121 related articles for article (PubMed ID: 10823374)
21. High-throughput liquid chromatography-tandem mass spectrometric analysis of sirolimus in whole blood.
Wallemacq PE; Vanbinst R; Asta S; Cooper DP
Clin Chem Lab Med; 2003 Jul; 41(7):921-5. PubMed ID: 12940519
[TBL] [Abstract][Full Text] [Related]
22. A microparticle enzyme immunoassay to measure sirolimus.
Holt DW; Moreton M; Laamanen K; Johnston A
Transplant Proc; 2005; 37(1):182-4. PubMed ID: 15808587
[TBL] [Abstract][Full Text] [Related]
23. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
Westley IS; Taylor PJ; Salm P; Morris RG
Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of microparticle enzyme immunoassay against HPLC-mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients.
Salm P; Rutherford DM; Taylor PJ; Black MJ; Pillans PI
Clin Biochem; 2000 Oct; 33(7):557-62. PubMed ID: 11124341
[TBL] [Abstract][Full Text] [Related]
25. Tacrolimus metabolite cross-reactivity in different tacrolimus assays.
Murthy JN; Davis DL; Yatscoff RW; Soldin SJ
Clin Biochem; 1998 Nov; 31(8):613-7. PubMed ID: 9876892
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic drug monitoring of immunosuppressants by liquid chromatography-mass spectrometry.
McShane AJ; Bunch DR; Wang S
Clin Chim Acta; 2016 Feb; 454():1-5. PubMed ID: 26721314
[TBL] [Abstract][Full Text] [Related]
27. Is microparticle enzyme-linked immunoassay (MEIA) reliable for use in tacrolimus TDM? Comparison of MEIA to liquid chromatography with mass spectrometric detection using longitudinal trough samples from transplant recipients.
Napoli KL
Ther Drug Monit; 2006 Aug; 28(4):491-504. PubMed ID: 16885716
[TBL] [Abstract][Full Text] [Related]
28. Quantification of sirolimus and everolimus by immunoassay techniques: test specificity and cross-reactivity evaluation.
Pieri M; Miraglia N; Gentile A; Polichetti G; Castiglia L; Federico S; Sabbatini M; Basile V; Tarantino G; Acampora A; Capone D
Int J Immunopathol Pharmacol; 2008; 21(3):585-94. PubMed ID: 18831925
[TBL] [Abstract][Full Text] [Related]
29. Comparison of binding characteristics of four rapamycin metabolites to the 14 and 52 kDa immunophilins with their pharmacologic activity measured by the mixed-lymphocyte culture assay.
Goodyear N; Murthy JN; Gallant HL; Yatscoff RW; Soldin SJ
Clin Biochem; 1996 Aug; 29(4):309-13. PubMed ID: 8828961
[TBL] [Abstract][Full Text] [Related]
30. The relative proportions of sirolimus metabolites in blood using HPLC with mass-spectrometric detection.
Holt DW; McKeown DA; Lee TD; Hicks D; Cal P; Johnston A
Transplant Proc; 2004 Dec; 36(10):3223-5. PubMed ID: 15686732
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a microparticle enzyme immunoassay for the measurement of sirolimus in whole blood (Abbott IMx sirolimus).
Scholer A; Von Rickenbach R; Faffa G; Vetter B
Clin Lab; 2006; 52(7-8):325-34. PubMed ID: 16955630
[TBL] [Abstract][Full Text] [Related]
32. Radioreceptor assay for sirolimus in patients with decreased platelet counts.
Goodyear N; Napoli KL; Murthy JN; Kahan BD; Soldin SJ
Clin Biochem; 1997 Oct; 30(7):539-43. PubMed ID: 9399022
[TBL] [Abstract][Full Text] [Related]
33. CEDIA sirolimus assay compared with HPLC-MS/MS and HPLC-UV in transplant recipient specimens.
Westley IS; Morris RG; Taylor PJ; Salm P; James MJ
Ther Drug Monit; 2005 Jun; 27(3):309-14. PubMed ID: 15905801
[TBL] [Abstract][Full Text] [Related]
34. Analytical performance of microparticle enzyme immunoassay and HPLC-tandem mass spectrometry in the determination of sirolimus in whole blood.
Salm P; Taylor PJ; Pillans PI
Clin Chem; 1999 Dec; 45(12):2278-80. PubMed ID: 10585368
[No Abstract] [Full Text] [Related]
35. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation.
Khoschsorur G; Fruehwirth F; Zelzer S; Stettin M; Halwachs-Baumann G
Clin Chim Acta; 2007 May; 380(1-2):217-21. PubMed ID: 17320846
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous on-line extraction and analysis of sirolimus (rapamycin) and ciclosporin in blood by liquid chromatography-electrospray mass spectrometry.
Kirchner GI; Vidal C; Jacobsen W; Franzke A; Hallensleben K; Christians U; Sewing KF
J Chromatogr B Biomed Sci Appl; 1999 Jan; 721(2):285-94. PubMed ID: 10052701
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the Pro-Trac tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of tacrolimus levels in patients after kidney, heart, and liver transplantation.
Winkler M; Christians U; Baumann J; Gonschior AK; Wonigeit K; Pichlmayr R
Ther Drug Monit; 1996 Dec; 18(6):640-6. PubMed ID: 8946659
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of high-resolution liquid chromatography versus microparticle enzyme immunoassay for the measurement of sirolimus levels in renal transplantation].
Asensi Díez R; Quesada Sanz MP; Valverde Molina E; de Ramón Garrido E; Gómez Maldonado J; Muñoz Castillo I
Farm Hosp; 2006; 30(3):142-8. PubMed ID: 16999560
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients.
Salm P; Warnholtz C; Boyd J; Arabshahi L; Marbach P; Taylor PJ
Clin Biochem; 2006 Jul; 39(7):732-8. PubMed ID: 16725133
[TBL] [Abstract][Full Text] [Related]
40. Recent development in application of high performance liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressants.
Yang Z; Wang S
J Immunol Methods; 2008 Jul; 336(2):98-103. PubMed ID: 18547583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
